Pharmafile Logo
Pharmafocus logo
Advanced Search
top_ten_stories

Top Ten articles in the Pharma Industry this week

September 30, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Coming towards the end of September, we’ve had some major developments in drug trials and bad news for some of …

News
cancer_drugs_-_credit_derek_k

€10.2 billion lost every year across the EU due to fake medicines

September 30, 2016
Manufacturing and Production, Medical Communications EU, European Union Intellectual Property Office, France, Germany, Italy, Spain, united kingdom

A report commissioned by the European Union Intellectual Property Office has shown that a staggering amount of money, €10.2 billion, …

News
download

Hanmi Pharma shares crash after shock contract termination

September 30, 2016
Manufacturing and Production, Medical Communications, Research and Development Boehringer Ingelheim, Genentech, Germany, HM61713, Hanmi Pharmaceutical, Tagrisso, south korea

News broke on 29 September that Hanmi Pharma, South Korea’s leading drug maker, had signed a $910 million deal with …

News

NICE rejects Lilly lung cancer drug, recommends Bayer’s Xofigo and Amgen’s Imlygic

September 30, 2016
Medical Communications, Sales and Marketing Imlygic, NICE, Portrazza, xofigo

The National Institute of Health and Care Excellence has issued final guidance rejecting Eli Lilly’s Portrazza (necitumumab) for the treatment …

News
brian_mcnamara

GSK appoints Brian McNamara chief of consumer health division

September 29, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brian McNamara, Emma Walmsley, GlaxoSmithKline

GlaxoSmithKline PLC has named Brian McNamara the head of its consumer-health division. The new comes a week after the announcement …

Appointment
abbvie-singapore

AbbVie opens its $300 million manufacturing plant in Singapore

September 29, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Asia, Singapore

AbbVie’s new Singapore based manufacturing plant is expected to be fully operational by late 2018. The plant is expected to …

News

The October issue of Pharmafocus is now live!

September 29, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, Pharmafocus new issue

The latest edition of Pharmafocus is available online now.

News
janssen_stairs_1

Johnson & Johnson failed to inform FDA over faulty blood testing device in Phase III trial

September 29, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Johnson & Johnson, Xarelto, phase III, warfarin

The British Medical Journal, after its own investigation, found that Janssen knew early into the Phase III trial, known as …

News
novonordisk

Novo Nordisk to cut 2% of its entire workforce

September 29, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Denmark, Novo Nordisk, diabetes, insulin, job cuts, job losses

Novo Nordisk, headquartered in Bagsvaerd, Denmark, has taken the decision to lose 1,000 of its workforce from a total global …

News
eylea-product-box-md

NICE approves Bayer’s Eylea for NHS use

September 28, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Eylea, NICE

Bayer has announced that its Eylea (aflibercept) drug has received a final recommendation from NICE for the treatment of visual …

News
laboratory

GW Pharma releases positive data on cannabidiol-based Phase III trial

September 28, 2016
Research and Development Epidiolex, GW Pharmaceuticals, Marijuana, Medical marijuana, cannabis

GW Pharmaceuticals’ Epidiolex is designed to treat seizures in a rare form of epilepsy called Lennox-Gaustaut Syndrome. GW pharmaceuticals published …

News
malaysia-645561_960_720

Malaysian pharmaceutical market set to grow to $3.6 billion by 2020

September 28, 2016
Research and Development

The report, by GlobalData, states that the primary reasons behind this growth are linked to medical tourism, a lack of …

News
abbvie_0

AbbVie and Eisai celebrate approval of new Humira indication

September 28, 2016
Research and Development, Sales and Marketing AbbVie, Eisai, Humira

AbbVie and Eisai have announced the Japanese approval of a new indication for the former’s anti-TNF-α monoclonal antibody formulation Humira …

News
mark_zuckerberg_-_south_by_southwest_2008

Zuckerberg appoints AstraZeneca’s Cornelia Bargmann

September 28, 2016
Research and Development AstraZeneca, Facebook, Mark Zuckerberg, Priscilla Chan

Zuckerberg and Chan have committed $3 billion of their own money to setting up the health initiative that has an …

News
china-pharmaceutical-industry

80% of Chinese clinical trials’ data fabricated

September 28, 2016
Manufacturing and Production, Research and Development China, Fabrication, corruption, report

The government review of clinical trial practise involved 1,622 programs of new pharmaceutical drugs waiting upon government approval to begin …

News
gilead-sciences

Provisional NICE recommendation for Gilead’s Hepatitis C treatment

September 28, 2016
Research and Development, Sales and Marketing Epclusa, NICE, hepatitis C

NICE has issued provisional guidance recommending the use of Gilead Sciences’ Epclusa (sofosbuvir 400 mg/velpatasvir 100 mg) for the treatment …

News

Merck elects Isabel De Paoli as CSO

September 27, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CSO, Merck, appointment

German pharma firm Merck has appointed Isabel De Paoli to the position of chief science officer in addition to her …

Appointment
amgen_hq

Amgen’s Kyprolis disappoints in Phase III trial

September 27, 2016
Manufacturing and Production, Research and Development Amgen, Kyprolis, phase III

Amgen was relying on the results of the trial to justify its $10.4 billion purchase of Onyx Pharmaceuticals, acquiring Kyprolis …

News
cancer-389921_960_720

Kite Pharma flying high after promising Car-T trial

September 27, 2016
Manufacturing and Production, Research and Development Cancer, Cart-T, kite pharma

Cart-T cell drugs are made by genetically altering patients’ T-cells to add a component of antibodies that make them better …

News
heather_bresch_2

Price-hiked EpiPen profits 66% higher than Mylan CEO claimed

September 27, 2016
Business Services, Manufacturing and Production, Sales and Marketing Heather Bresch, Mylan, epipen

In the latest development in the Mylan EpiPen scandal, it has been discovered that CEO Heather Bresch lied to US …

News
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026